Evidence map›Paper›PMID 41382236›Full record

ArticleMalaria journal2025

Investigating factors enabling the acceptability of perennial malaria chemoprevention implementation in Osun State, Nigeria: evidence from a qualitative process evaluation.

Michael Ekholuenetale, Joshua Oyeniyi Aransiola, Chinazo Ujuju, Nnenna Ogbulafor, Olufemi Oroge, Rufai-Ahmed Garba, Semiu Adebayo Rahman, Kolawole Maxwell, Ridwan Akorede Awosanya, Mary Abosede Adekola and 5 more

Abstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Michael EkholuenetaleMalaria Consortium, Abuja, Federal Capital Territory, Nigeria.
Joshua Oyeniyi AransiolaDepartment of Sociology and Anthropology, Obafemi Awolowo University, Ile-Ife, Nigeria.
Chinazo UjujuMalaria Consortium, Abuja, Federal Capital Territory, Nigeria. chinazoujuju@gmail.com.
Nnenna OgbulaforNational Malaria Elimination Programme (NMEP), Abuja, Federal Capital Territory, Nigeria.
Olufemi OrogeOsun State Ministry of Health, Osogbo, Osun State, Nigeria.
Rufai-Ahmed GarbaNational Emergency Routine Immunization Coordination Centre (NERRIC), National Primary Health Care Development Agency (NPHCDA), Abuja, Federal Capital Territory, Nigeria.
Semiu Adebayo RahmanMalaria Consortium, Abuja, Federal Capital Territory, Nigeria.
Kolawole MaxwellMalaria Consortium, Abuja, Federal Capital Territory, Nigeria.
Ridwan Akorede AwosanyaMalaria Consortium, Abuja, Federal Capital Territory, Nigeria.
Mary Abosede AdekolaMalaria Consortium, Abuja, Federal Capital Territory, Nigeria.
Benjamin Bukky IlesanmiMalaria Consortium, Abuja, Federal Capital Territory, Nigeria.
Adekemi AjayiMalaria Consortium, Abuja, Federal Capital Territory, Nigeria.
Oluyemi Aduke OgundunMedical Services and Disease Control, State Primary Health Care Development Board, Osogbo, Osun State, Nigeria.
Olusola OresanyaMalaria Consortium, Abuja, Federal Capital Territory, Nigeria.
James K TibenderanaMalaria Consortium Headquarters, London, E2 9DA, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalaria remains a life-threatening disease predominantly in resource-constrained settings including Nigeria. Despite the availability of interventions to prevent, diagnose and treat malaria, children under five years remain vulnerable. Perennial malaria chemoprevention (PMC) is an effective intervention to prevent malaria in children under 24 months. However, the uptake of PMC may be affected by community acceptability of the intervention. The study explored the acceptability of PMC in Osun State, Nigeria.

methodsFocus group discussions and key informant interviews were used to gather caregivers, community leaders, fathers of children less than 24 months of age and health workers' perspectives on PMC in Osun State, Nigeria. Thematic analysis was conducted using ATLAS.ti 24.

resultsParticipants reported acceptability of PMC delivered through expanded programme on immunization (EPI) platform. Acceptability was influenced by perceived effectiveness, child-friendliness and free health services as well as whether individuals accept conventional medicines and the delivery platform. On the other hand, lack of funds for transportation and the fear of side effects negatively affected PMC acceptability. Caregivers reported the attitudes of health workers towards the intervention influenced their acceptance or negative behaviour towards PMC. Religious leaders also accepted PMC as it did not contradict their faith.

conclusionSeveral factors affect acceptability of PMC. To maximize acceptance that would lead to increased uptake of PMC, programmes should identify factors within their context that influence acceptability and employ appropriate strategies to maintain high acceptability.

Indexed as

AntimalarialsChemopreventionMalariaPatient Acceptance of Health CareAdultChild, PreschoolFemaleFocus GroupsHumansInfantInterviews as TopicMaleMiddle AgedNigeriaYoung AdultAntimalarialsChild healthChildren under 24 monthsMalariaNigeriaPerennial malaria chemoprevention

Identifiers

PMID41382236
PMCPMC12801469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.